This move is archived. Current quotes and coverage live on the stock page.
Get MSCL alerts:
Satellos Bioscience Inc. has seen a remarkable surge in its stock price, climbing over 10% in just one trading day.
On the TSX, Satellos Bioscience Inc. (MSCL.TO) experienced a significant boost, closing at CA$11.30, marking a 10.78% increase in its stock price. This surge comes as the company continues to make strides in the biotech sector, particularly in its innovative approaches to treating Duchenne muscular dystrophy.
Investor takeaway: Investors are responding positively to Satellos' ongoing developments and potential future milestones, which could further enhance its market position.
Advertisement
Satellos Bioscience Inc.
MSCL.TO
MSCL.TO
Satellos Bioscience Inc.
WealthAwesomeMarket cap
$275.81M
52W high
$18.98
52W low
$7.32
1W change
-6.14%
Beta
1.14
Analyst Price Targets
Based on analyst covering MSCL · as of Sep 17, 2026
Wall Street analysts forecast MSCL stock price to rise 35.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$17.67
+35.9% Upside
Current Price
C$13.00
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MSCL's historical volatility
30-Day Vol
51.6%
Annualized
90-Day Vol
71.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$15.58
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.83 | C$11.57 – C$16.53 |
| 60 trading days | C$14.68 | C$11.41 – C$18.88 |
| 90 trading days | C$15.58 | C$11.44 – C$21.21 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Satellos Bioscience Inc. Rises 10.78% in One Day
With a market cap of CA$212 million, Satellos is making waves in the biotech industry, driven by its innovative treatment approaches.
Bull case
The recent rise in stock price shows that investors are gaining confidence in Satellos' clinical advancements and its potential for future growth, especially following promising results from its Phase 1b trials.
Bear case
Even with this positive momentum, investors should stay cautious. The biotech sector can be unpredictable, and future results are not guaranteed.
Market Performance Overview
Advertisement
Satellos Bioscience Inc. closed at CA$11.30, reflecting a robust increase of 10.78% in its stock price during the last trading session. This surge indicates a positive sentiment among investors, likely fueled by the company's ongoing research and development efforts.
Investor Sentiment and Future Outlook
The increase in stock price suggests growing confidence in Satellos' potential, particularly after recent announcements regarding its clinical trials and treatment methodologies. Investors are closely monitoring further developments, especially as the company approaches significant clinical milestones. For more insights on Satellos' performance, visit our detailed analysis on MSCL.TO.
Understanding the Biotech Landscape
As Satellos continues to innovate in the biotech field, particularly in treatments for Duchenne muscular dystrophy, it's essential for investors to stay informed about the broader market dynamics. The biotech sector is known for its volatility, and while current trends are promising, they can change rapidly. For ongoing updates, check our MSCL.TO page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
